UK Life and Pensions has delivered resilient performance as the repositioning programme continues.
The company's SIPP product is continuing to demonstrate strong performance with APE sales over the nine months to 30 September 2005 of £88 million against £24m last year (equivalent product). As we focus on the more profitable SIPP business, APE sales of UK individual pensions other than SIPP in the nine months to 30 September 2005 were £101 million (2004: £190m).
Group pensions APE sales over the nine months to 30 September 2005 were £277 million (2004: £264m). Within the Group pensions market, the company has however seen a reduction in volumes in the third quarter. A selective approach to pricing new business opportunities is being taken, with the aim of improving profitability of this line of business.
APE sales of UK Life and Pensions investment products in the nine months to 30 September 2005 were £151 million (2004: £87 million), supported by an expanding product range and strong underlying investment performance.
The Protection market remains highly competitive, with fewer house sales and increasingly strong price competition.
Standard Life Investments has recorded its strongest quarterly trading period. Worldwide gross fund inflows for the third quarter rose to over £1bn, up from £233m in the same period last year. Standard Life Investments now manages £112.5bn, of which third party funds under management represent £25.3 billion, an increase of £3 billion over the last three months and almost £7 billion for the year to date. This includes several significant pension fund mandate wins during the third quarter, driven in part by strong investment performance.
Standard Life Healthcare achieved sales of £15 million (2004: £23 million) during the nine months to 30 September 2005, reflecting a more focused approach on assessing the profitability of new business opportunities. During the period, the company signed a sale and purchase agreement for the Private Medical Insurance business of FirstAssist, which on completion (expected in the first quarter of 2006) should place Standard Life Healthcare as the third largest provider in the UK health insurance market.
The UK mortgage market remains competitive and Standard Life Bank's gross mortgage lending for the nine months to 30 September 2005 was £2,290 million (2004: £3,329 million). The mortgage balance ended the period at £10.5 billion (31 December 2004 £10.2 billion).
Standard Life Canada's APE insurance sales in the nine months to 30 September 2005 were £119 million (2004: £117 million). Individual annuities continue to see year on year growth, although Group annuities saw a fall in APE driven largely by a reduction in regular premium business.
Total APE new insurance business written outside the UK and Canada in the nine months to 30 September 2005 was £87 million (2004: £105 million).
In line with the rest of the German market, sales in Standard Life Germany fell below normal levels following last year's business surge ahead of the changes in taxation of pensions, which had a particular impact in the fourth quarter of 2004. In the nine months to 30 September 2005 APE sales were £51 million (2004: £71million). Standard Life Ireland's repositioning exercise continues and APE sales in the nine months to 30 September 2005 were £17 million (2004: £18 million).
In India the joint venture HDFC Standard Life demonstrated strong growth, with APE sales of £65 million (of which Standard Life's share was £17 million) in the nine months to 30 September 2005 (2004: £23 million of which Standard Life's share was £7 million). The Chinese joint venture Heng An Standard Life was granted permission to open a branch in Beijing, following the opening of its first branch in Qingdao earlier this year. The Beijing branch will open for business in early 2006. The sale of Standard Life's Spanish subsidiary, Prosperity, was completed in September.
Group Chief Executive, Sandy Crombie, commented:
"2005 is a pivotal year for Standard Life and the repositioning of our business continues. Group funds under management have reached £124bn, and total new insurance business, represented by single premiums plus new regular premiums, has risen by almost 17% from £3.9bn to £4.6bn. Although we expect many of our chosen markets such as group and individual pensions to remain competitive, the results for this third quarter demonstrate our continued progress in establishing a sound base from which to grow the business."
Notes to Editors